[July 07, 2014]

Research and Markets: Patenting Biotech in Europe and the USA Seminar: How to Overcome Obstacles to Obtaining Protection for your Invention - 25th-26th September, London UK

Research and Markets (http://www.researchandmarkets.com/research/9537x9/patenting_biotech) has announced the addition of the "Patenting Biotech in Europe and the USA - How to overcome obstacles to obtaining protection for your invention" conference to their offering.

25 & 26 September 2014 - The Rembrandt Hotel, London

Research and development in the field of life sciences is extremely time-consuming and costly. Clearly defined and secure patent rights to biotech inventions are essential to obtain funding for research, and to subsequently recoup the investment.

In an attempt to restrict the granting of patents with broad claims, many patent offices have imposed stringent and complicated requirements on biotech patent applications. In addition, there are still significant differences between US and European patent practice.

This seminar, using practical examples, will highlight these differences as they apply to biotech, and offer delegates solutions to help them overcome the obstacles to obtaining protection for their inventions.

ISSUES TO BE ADDRESSED DURING THIS SEMNAR WILL INCLUDE:

Obstacles to Patenting in the European Patent Office

• Compounds of nature
• The limits for diagnostic claims
• The limits for personalised medicine claims
• Early patent applications and the plausibility test
• How to properly disclose an invention in patent applications
• When to submit documents, evidence and claim requests
• Poisonous divisional
• Essentially biological methods and plant patents
• The interplay of proceedings before the EPO with national courts

Obstacles to Patenting in the United States

• Subject-matter eligibility
• Methods - medical, diagnostic, genetic
• Scope of disclosure
• Obviousness
• Definiteness

Obstacles to Enforcement in the United States

• Obviousness-type double patenting
• DJ actions and licensing
• Expanded post-grant review
• Claim construction

Key Topics Covered:

THE UNITED STATES

• Supreme Court destabilises US Patent Law Programme
• Obstacles to patenting in the United States Subject matter eligibility: most recent sea change in the law
• Scope of disclosure: developed over more than a decade
• Obviousness
• Definiteness
• Obstacles to enforcement in the United States
• DJ actions and licensing
• Expanded post-grant review
• Claim construction

THE EUROPEAN PATENT OFFICE

• Obstacles to Patenting in the EPO
• Compounds of nature are generallypatentable in the EPO
• Diagnostics, Personalised Medicine and Treatment Regimens
• The plausibility test: a general bar to patentability of inventions for which applications were filed too early
• The EPO's critical approach to what a patent application really discloses
• The EPO's critical approach to procedural issues
• When to file divisionals, and how they can be poisonous
• The patentability of plant inventions: the EPO and its vegetable saga
• The interplay between the EPO and national jurisdictions

For more information visit http://www.researchandmarkets.com/research/9537x9/patenting_biotech

[ Back To TMCnet.com's Homepage ]